cobas SARS-CoV-2 Test
Reliable, high-volume testing for the detection of novel coronavirus (SARS-CoV-2)
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
It is a really very tough analyzer for mid level usage.
Blood Chemistry Analyzer
It delivers accurate and reliable result, user friendly, has great throughput per hour, accessible maintenance service, reagents supplies and consumables readily available.
Review Date: 11 Feb 2022 | Roche
Intuitive product and excellent technical support
Detection of SARs-CoV-2
The assay and platform are intuitive and easy to use. Roche's molecular technical support is always impressively prompt and helpful from large issues to small questions.
Review Date: 19 Dec 2021 | Roche
Excellent results.
SARS-CoV-2 molecular testing
High quality, reliable and comparable results - the backbone of Australian COVID response.
Review Date: 31 Jul 2021 | Roche
Great results.
Analysis of antibodies
Easy to use, high quality, and the result are good.
Review Date: 23 Jul 2021 | Roche
Useful test!
Analyze SARS-CoV-2 N-protein Ab qualitatively and S-protein Ab quantitatively in plasma
The tests are quite effective in our laboratory. Internal quality control yields reproducible results with high consistency. All external quality controls have also passed so far. There are 2 different reagent kits to determine N or S protein, that can be useful in assessing whether the patient has come to contact with the disease or has been vaccinated. The 2 reagent kits have a very similar name though, causing some mix-ups in a laboratory that is highly automated and working 24/7 with a large number of different laboratory technicians rotating.
Review Date: 1 Jul 2021 | Roche
Great test. Quick and reliable results for a reasonable price. Recommended!
SARS Cov-2 testing
Great test. Quick and reliable results for a reasonable price. Recommended!
Review Date: 7 Jun 2021 | Roche
The cobas® SARS-CoV-2 Test provides reliable and high-quality results for the improved management of COVID-19, in individuals suspected of COVID-19 by their healthcare provider, and those without symptoms or other reasons to suspect COVID-19. Healthcare professionals can use this test to assess if patients are at risk of developing the disease by this pathogen, which can contribute to severe respiratory distress, complications, and potential death.
The test is for use on the fully-automated cobas® 6800/8800 Systems under FDA Emergency Use Authorization (EUA) for individual samples and for pooled samples containing up to and including six individuals. This test, including the pooling workflow, is also available as a CE-IVD test for countries accepting the CE-mark.
Features and benefits of the cobas® SARS-CoV-2 Test
The cobas® SARS-CoV-2 Test is a single-well dual target assay, which includes both specific detection of SARS-CoV-2 and pan-Sarbecovirus detection for the Sarbecovirus subgenus family that includes SARS-CoV-2. The assay has a full-process negative control, positive control and internal control. Two kit sizes accommodating either 192 or 480 test reactions are available.
Claims include:
- Use of nasal, nasopharyngeal and oropharyngeal swab sample types
- Use of collection and transport media
- cobas PCR Media Dual Swab Kit
- Uni Swab
- PCR Media Kit
- Copan Universal Transport Media (UTM-RT)
- BD™ Universal Viral Transport (UVT)
- 0.9% Physiological Saline
- Please refer to the IFU for acceptable sample type and collection device combinations
